Kamal S Saini

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 17

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Arun K Mankan, Nagender Mankan, Begona de Las Heras, Shakti H Ramkissoon, Olga Bodriagova, Laura Vidal, Enrique Grande, Kamal S Saini
Bladder Cancer, Loss of Y Chromosome, and New Opportunities for Immunotherapy. Advances in therapy 41 (3) (2024)
Arun K Mankan, Nagender Mankan, Begona de Las Heras, Shakti H Ramkissoon, Olga Bodriagova, Laura Vidal, Enrique Grande, Kamal S Saini
Bladder Cancer, Loss of Y Chromosome, and New Opportunities for Immunotherapy. Advances in therapy 41 (3) (2024)
Arun K Mankan, Abhishek Shankar, Sewanti Limaye, Sewanti A Limaye, Prajakta Nachane, Navneet Singh, Shekhar Dawkhar, Ullas Batra, Amol Bhosekar, Sandip Ganguly, Pramod Gawli, Khokan Debnath, Vivek Padalalu, Prasanth Reddy, Shanthi Sundaramoorthy, K K Naveen, Shailesh Bondarde, Praveen Kumar, Sanish Davis, Shakti H Ramkissoon, Raju Titus Chacko, Laura Vidal, Isagani Chico, Andrew Hegedus, Sudeep Gupta, Kamal S Saini
Cancer Trials Ecosystem in India-Ready for Prime Time? JCO global oncology 10 (2024)
Arun K Mankan, Nagender Mankan, Begona de Las Heras, Shakti H Ramkissoon, Olga Bodriagova, Laura Vidal, Enrique Grande, Kamal S Saini
Bladder Cancer, Loss of Y Chromosome, and New Opportunities for Immunotherapy. Advances in therapy 41 (3) (2024)
Arun K Mankan, Nagender Mankan, Begona de Las Heras, Shakti H Ramkissoon, Olga Bodriagova, Laura Vidal, Enrique Grande, Kamal S Saini
Bladder Cancer, Loss of Y Chromosome, and New Opportunities for Immunotherapy. Advances in therapy (2024)
Arun K Mankan, Abhishek Shankar, Sewanti Limaye, Sewanti A Limaye, Prajakta Nachane, Navneet Singh, Shekhar Dawkhar, Ullas Batra, Amol Bhosekar, Sandip Ganguly, Pramod Gawli, Khokan Debnath, Vivek Padalalu, Prasanth Reddy, Shanthi Sundaramoorthy, K K Naveen, Shailesh Bondarde, Praveen Kumar, Sanish Davis, Shakti H Ramkissoon, Raju Titus Chacko, Laura Vidal, Isagani Chico, Andrew Hegedus, Sudeep Gupta, Kamal S Saini
Cancer Trials Ecosystem in India-Ready for Prime Time? JCO global oncology 10 (2024)
Abhinava K Mishra, Ashna Gupta, Gunjan Dagar, Dayasagar Das, Abhishek Shankar, Shabirul Haque, Chandra Prakash Prasad, Archana Singh, Ajaz Ahmad Bhat, Muzafar A Macha, Moez Benali, Kamal S Saini, Rebecca Ann Previs, Deepak Saini, Dwaipayan Saha, Preyangsee Dutta, Aseem Rai Bhatnagar, Mrinalini Darswal, Abhishek Shankar, Mayank Singh
CAR-T-Cell Therapy in Multiple Myeloma: B-Cell Maturation Antigen (BCMA) and Beyond. Vaccines 11 (11) (2023)
Kelsey McDonald, Earl Seltzer, Mary Lu, Stefan Diaz Gaisenband, Cassandra Fletcher, Patrick McLeroth, Kamal S Saini
Quantifying the impact of the COVID-19 pandemic on clinical trial screening rates over time in 37 countries. Trials 24 (1) (2023)
Olga Bodriagova, Rebecca Ann Previs, Lydia Gaba, Abhishek Shankar, Laura Vidal, Kamal S Saini
Recent Advances in Gynecological Malignancies: Focus on ASCO 2023. Oncology and therapy (2023)
Heidi Chwan Ko, Rebecca A Previs, Kyle C Strickland, Jonathan Klein, Brian Caveney, Chiara Chiruzzi, Marcia Eisenberg, Eric A Severson, Shakti Ramkissoon, Kamal S Saini
Is HER2-Low a New Clinical Entity or Merely a Biomarker for an Antibody Drug Conjugate? Oncology and therapy (2023)
Begoña de Las Heras, Adam Daehnke, Kamal S Saini, Melissa Harris, Kenneth Morrison, Ariel Aguilo, Isagani Chico, Laura Vidal, Robin Marcus
Role of decentralized clinical trials in cancer drug development: Results from a survey of oncologists and patients. Digital health 8 (2022)
Maryland Rosenfeld Franklin, Suso Platero, Kamal S Saini, Giuseppe Curigliano, Steven Anderson
Immuno-oncology trends: preclinical models, biomarkers, and clinical development. Journal for immunotherapy of cancer 10 (1) (2022)
Kamal S Saini, Diogo Martins-Branco, Marco Tagliamento, Laura Vidal, Navneet Singh, Kevin Punie, Monika Lamba Saini, Isagani Chico, Giuseppe Curigliano, Evandro de Azambuja, Matteo Lambertini
Emerging issues related to COVID-19 vaccination in patients with cancer. Oncology and therapy (2021)
Kamal S Saini, Kevin Punie, Chris Twelves, Stefanella Bortini, Evandro de Azambuja, Steven Anderson, Carmen Criscitiello, Ahmad Awada, Sherene Loi
Antibody-drug conjugates, immune-checkpoint inhibitors, and their combination in breast cancer therapeutics. Expert opinion on biological therapy 21 (7) (2021)
Kamal S Saini, Christopher Tweleves
Determining lines of therapy in patients with solid cancers: a proposed new systematic and comprehensive framework. British journal of cancer 125 (2) (2021)
Kamal S Saini, Diogo Martins-Branco, Marco Tagliamento, Laura Vidal, Navneet Singh, Kevin Punie, Monika Lamba Saini, Isagani Chico, Giuseppe Curigliano, Evandro de Azambuja, Matteo Lambertini
Emerging issues related to COVID-19 vaccination in patients with cancer. Oncology and therapy 9 (2) (2021)
Begoña de Las Heras, Kamal S Saini, Frances Boyle, Felipe Ades, Evandro de Azambuja, Ivana Bozovic-Spasojevic, Marco Romano, Marta Capelan, Rajeev Prasad, Pugazhenthi Pattu, Christophe Massard, Chia Portera, Monika Lamba Saini, Brajendra Prasad Singh, Ramachandran Venkitaraman, Richard McNally, Manuela Leone, Enrique Grande, Sudeep Gupta
Cancer Treatment and Research During the COVID-19 Pandemic: Experience of the First 6 Months. Oncology and therapy 8 (2) (2020)

Kamal S Saini.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kamal S Saini